SPARROW PHARMACEUTICALS
Dead / Abandoned — Abandoned — failure to respond (as of 17 May 2023)
What this means for you
This application is over — abandoned 28 Mar 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90635886
- Mark type
- Design + words
- Filed
- 09 Apr 2021
- Abandoned
- 28 Mar 2023
- Attorney of record
- Sean D. O'Brien
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of allergic states, collagen diseases, dermatologic diseases, edematous states, endocrine disorders, gastrointestinal diseases, hematological disorders, infectious diseases, neoplastic diseases, nervous system disorders, ophthalmic diseases, respiratory disorders, and rheumatic disorders
- Class 044 — Medical, beauty and agricultural services: providing health information via a website; providing information to patients in the field of administering medications; providing medical information from a web site
Owner
- Sparrow Pharmaceuticals, Inc., Portland, OR, US
Prosecution history
- 17 May 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 17 May 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 17 May 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 27 Sept 2022 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 27 Sept 2022 — FINAL REFUSAL E-MAILED
- 27 Sept 2022 — FINAL REFUSAL WRITTEN
- 11 Aug 2022 — EXAMINER'S AMENDMENT ENTERED
- 11 Aug 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 11 Aug 2022 — EXAMINERS AMENDMENT E-MAILED
- 11 Aug 2022 — EXAMINERS AMENDMENT -WRITTEN
- 07 Jul 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Jul 2022 — NON-FINAL ACTION E-MAILED
- 07 Jul 2022 — NON-FINAL ACTION WRITTEN
- 27 May 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 May 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE